Sharon Moor-Gino

Haifa, HA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Acupuncture for Treating Cellulitis: A Pilot Study.

Acupuncture for Treating Cellulitis: A Pilot Study.

Journal: The Israel Medical Association journal : IMAJ

Published: April 02, 2025

Real-World Adherence to a Delirium Screening Test Administered by Nurses and Medical Staff during Routine Patient Care.

Real-World Adherence to a Delirium Screening Test Administered by Nurses and Medical Staff during Routine Patient Care.

Journal: Brain sciences

Published: June 07, 2024

MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin Level.

MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin Level.

Journal: Journal of clinical medicine

Published: August 04, 2023

Validation of a viable delirium detection test performed by nurses and physicians during routine patient care.

Validation of a viable delirium detection test performed by nurses and physicians during routine patient care.

Journal: BMC geriatrics

Published: April 30, 2023

Early Detection and Intervention for Patients with Delirium Admitted to the Department of Internal Medicine: Lessons from a Pilot Initiative.

Early Detection and Intervention for Patients with Delirium Admitted to the Department of Internal Medicine: Lessons from a Pilot Initiative.

Journal: Dementia and geriatric cognitive disorders extra

Published: March 16, 2021

Venetoclax is safe and efficacious in relapsed/refractory AML.

Venetoclax is safe and efficacious in relapsed/refractory AML.

Journal: Leukemia & lymphoma

Published: May 19, 2020

Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long-term follow-up of a multi-center prospective study.

Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long-term follow-up of a multi-center prospective study.

Journal: American journal of hematology

Published: September 22, 2019

Acute Renal Failure Associated with Lenalidomide Treatment in Multiple Myeloma: A Rare Occurrence?

Acute Renal Failure Associated with Lenalidomide Treatment in Multiple Myeloma: A Rare Occurrence?

Journal: Anticancer research

Published: March 28, 2016

Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemia.

Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemia.

Journal: American journal of hematology

Published: August 16, 2015

Showing 1-9 of 9

Last Updated: 09/26/2026